Product image of Hyoscine Butylbromide Kalceks (Hyoscine Butylbromide) supplied by GNH India

Hyoscine Butylbromide Kalceks

Active Ingredient:
Hyoscine Butylbromide
Origin:
EU

Hyoscine Butylbromide Kalceks (Hyoscine Butylbromide)

Hyoscine Butylbromide, the active ingredient in Hyoscine Butylbromide Kalceks, is an anticholinergic presented as a sterile injectable solution for intramuscular, intravenous or subcutaneous use. It relaxes smooth‑muscle spasm and is used to relieve abdominal, biliary and renal colic in adult patients.
GNH India supplies Hyoscine Butylbromide Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hyoscine Butylbromide acts on smooth‑muscle receptors to relieve spasm in several gastrointestinal and urinary conditions.

  • Abdominal pain and cramps: reduces painful muscle contractions in the gut.
  • Gastrointestinal spasm: eases involuntary contractions of the intestinal wall.
  • Biliary colic: alleviates spasms of the biliary ducts.
  • Renal colic: diminishes ureteral smooth‑muscle spasm.
  • Urinary tract smooth‑muscle spasm: relaxes the bladder neck and urethra during spasmodic episodes.

How It Works

  • Hyoscine Butylbromide competitively blocks muscarinic acetylcholine receptors (M1–M5) on smooth‑muscle cells, preventing acetylcholine‑mediated contraction. This antagonism leads to relaxation of gastrointestinal, biliary, urinary and vascular smooth muscle, thereby decreasing spasm and associated pain without crossing the blood‑brain barrier.

Side Effects

Hyoscine Butylbromide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Dry mouth: reduced salivary secretion.
  • Blurred vision: temporary difficulty focusing.
  • Tachycardia: mild increase in heart rate.
  • Constipation: slowed intestinal transit.
  • Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects

  • Allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Severe hypotension: sudden drop in blood pressure.
  • Paralytic ileus: marked cessation of intestinal motility.
  • Acute glaucoma: rapid increase in intra‑ocular pressure.
  • Skin necrosis: rare severe skin ulceration.

Precautions & Warnings

Before using Hyoscine Butylbromide, clinicians should consider patient‑specific factors and monitor for adverse events.

  • Cardiac history: assess for arrhythmias or tachycardia risk.
  • Glaucoma: avoid in patients with narrow‑angle glaucoma.
  • Renal/hepatic function: adjust use if severe impairment is present.
  • Elderly patients: start with the lowest effective dose and monitor closely.
  • Known hypersensitivity: discontinue if allergic signs appear.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Hyoscine Butylbromide can interact with other medications that affect the autonomic nervous system or gastrointestinal motility.

Major Interactions (Avoid)

  • Other anticholinergic agents: additive anticholinergic burden may cause severe dry mouth, tachycardia, or urinary retention.
  • Potent antiarrhythmics (e.g., quinidine): may exacerbate cardiac conduction abnormalities.
  • Opioid analgesics: combined effect can markedly reduce gastrointestinal motility.

Moderate Interactions (Monitor Closely)

  • Antihistamines: may increase dry mouth and blurred vision.
  • Tricyclic antidepressants: potential for enhanced anticholinergic side effects.
  • Beta‑blockers: possible additive effect on heart rate.
  • Antihypertensives: monitor blood pressure for additive hypotensive effect.
  • CYP3A4 inhibitors: may modestly increase plasma levels, though metabolism is limited.

Frequently Asked Questions

Hyoscine Butylbromide Kalceks is employed to relieve smooth‑muscle spasm in abdominal pain, gastrointestinal cramping, biliary colic, renal colic, and urinary‑tract spasm. By relaxing the affected muscles, it helps reduce pain and discomfort associated with these conditions.

The drug blocks muscarinic acetylcholine receptors on smooth‑muscle cells, preventing acetylcholine from triggering contraction. This antagonism leads to muscle relaxation in the gastrointestinal, biliary, and urinary tracts, thereby decreasing spasm and related pain.

The prescribed dose is determined by the treating clinician based on the patient’s condition, severity of symptoms, and route of administration. Healthcare professionals adjust the amount to achieve optimal relief while minimizing side effects.

Safety data for use in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and it must be prescribed by a qualified healthcare provider.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with oral antispasmodics such as dicyclomine, Hyoscine Butylbromide is administered parenterally and has limited central nervous system penetration, reducing central side effects. It provides rapid onset of action for acute spasm relief, whereas oral agents may have slower onset and broader systemic effects.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly sealed to maintain sterility.

The medication is supplied as a sterile injectable solution and can be given intramuscularly, intravenously, or subcutaneously by a qualified healthcare professional. The route and rate of injection are selected according to the clinical situation and patient needs.

Serious adverse events include severe allergic reactions (anaphylaxis), marked hypotension, paralytic ileus, acute glaucoma, and skin necrosis. Prompt medical attention is required if any of these symptoms develop during treatment.

Patients with known hypersensitivity to hyoscine butylbromide or any excipients, those with narrow‑angle glaucoma, severe cardiac conduction disorders, or uncontrolled urinary retention should avoid this medication. Clinicians must evaluate each patient’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.